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Introduction 
 
Hearing loss (HL) is the most frequent form of 
sensory impairment in humans, with approxi-
mately 1-2 in 1000 infants being born with a seri-
ous HL (https://www.gov.uk/guidance/newborn-
hearing-screening-programme-overview). Over 70% 
of pre-lingual HL cases can be classified as non-
Abstract 
Background: Autosomal recessive non-syndromic hearing loss (ARNSHL), one of the global public health 
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syndromic HL (NSHL), where the hearing deficit 
is the only sign (1). HL can be inherited as auto-
somal recessive, autosomal dominant, mitochon-
drial, X- and Y-linked. Autosomal recessive mode 
of inheritance (ARNSHL) makes up 80% of the 
NSHL cases. ARNSHL is highly heterogeneous, 
for which over 100 mapped loci are known. The 
autosomal recessive loci are called DFNB fol-
lowed by a number corresponding to the order 
that the locus was first explained; DFNB1 to 
DFNB105 have been reported so far 
(http://hereditaryhearingloss.org). However, 
more than seventy different DFNB loci have 
been mapped for ARNSHL by homozygosity 
mapping, an effective method to locate genes 
causing ARNSHL in large consanguineous fami-
lies (2). 
The genetic etiology of ARNSHL in Iran has 
been studied by a number of independent studies 
with a special focus on the certain locus DFNB1 
(GJB2), as the most common cause of HL all 
over the world (3). Variants in the GJB2 
(NM_004004.5) could explain the etiology of 
ARNSHL in 4% to 35% of patients from differ-
ent origin, suggesting that GJB2 gene mutations 
account for a part of ARNSHL in Iran. (4, 5). On 
the other hand, Iran is a large country with many 
ethnic groups and high rate of the consanguine-
ous marriages (38.6% on average) (6). Thus, mu-
tations in certain loci may be increased within 
some ethnic groups (7). Therefore, population-
specific studies are necessary to identify other 
common loci and to determine the etiology of 
ARNSHL based on ethnicity. Until now, little 
data is available on the contribution of some fre-
quent loci among the Iranian ARNSHL; and have 
mostly focused on mixed populations from dif-
ferent provinces (8). Mutations in at least 40 
genes have been explained to cause ARNSHL in 
Iran. However, the contribution of their muta-
tions does not appear to occur at the same fre-
quencies across different ethnic groups (9). 
We applied the homozygosity mapping strategy 
to identify the relative contribution of 10 DFNB 
loci to ARNSHL in the studied cohort including 
60 ARNSHL families, which were negative for 
GJB2 mutations, from Isfahan and Hamedan 
provinces for the first time. This data could be 
applied to design a cheap and accurate panel for 
common genes causing ARNSHL in certain re-
gions of Iran and would lead to affordable testing 
and improved management of HL (10).  
 
Materials and Methods 
 
Families and clinical evaluations  
Totally, 60 unrelated consanguineous families 
with 3 or more hearing impaired patients and 
negative for GJB2 mutations were recruited from 
Isfahan and Hamedan provinces in the center 
and west of Iran in 2017.  
The Ethics Committee of the Isfahan University 
of Medical Sciences approved this project. All 
family members signed informed written consent 
prior to recruitment. They met the following cri-
teria: 1) confirmation of HL by Pure tone audi-
ometry (PTA) from 250-8000 Hz 2) the autoso-
mal recessive inheritance deduced through pedi-
gree analysis 3) existence of three or more affect-
ed members within the pedigree. A complete 
clinical investigation was performed to exclude 
environmental exposures and to determine the 
presence of syndromic findings in each family.  
 
DNA extraction  
Genomic DNA was extracted using Prime Prep 
Genomic DNA Extraction kit from blood 
(GeNet Bio, Korea) according to the manufac-
turer’s instruction. Qualitative and quantitative 
assessment of genomic DNA was checked using 
1.2% agarose gel and Nanospec cube biopho-
tometer (Nanolytik®, Dusseldorf, Germany). 
 
SLINK analysis and selection of DFNB loci 
Power of the pedigrees for linkage analysis was 
simulated by calculating SLINK, using FastSLink 
(ver.2.51) option of Easy linkage plus version 
5.05 software to predict the potential LOD score 
in a given family (11). Based on the literature re-
view of the most frequent loci, both globally and 
regionally, 10 loci were selected for screening. 
Screening sort tandem repeat (STR) markers were 
selected based on their physical distance found at 
NCBI UniSTS and NCBI Map Viewer 
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(http://www.ncbi.nlm.nih.gov). Primers for STR 
markers of each locus were mostly obtained 
through the Probe database 
(https://www.ncbi.nlm.nih.gov/probe). STR 
markers of each locus and their primer sequences 
are listed in Table 1. 
 
Table 1: The list of 10 DFNB loci screened in this study. The corresponding genes and characteristic of screening 
markers are shown 
 
locus 
(gene) 
STR Heterozygosity 
(%) 
Size(bp) Forward primer Reverse primer 
       
DFNB7-11 
(TMC1) 
D9S1876 81 132-152 GATGTACCCAGAGAAGTCTCG AGTGGTTACCATTTACCCAAG 
 D9S1124 76 252-276 GGTGCCCACCATACACTACT TCTAATCCTTCCTTCCCTCG 
 D9S301 78 205-251 CATGATGGTGGTCTCTGG GGTGGGGCTCAAAGAGTAG 
 D9S1799 91 139-178 TTGCCAACTATTTTAGCCC TGCAGTTTCAATCCACATC 
      
DFNB3 
(MYO15A) 
D17S953 81 119-131 ACTATCCGCCCAATACA AAGGGCTTGCTTTGAC 
 D17S1843 70 177-187 TGCACAGGCCAATTCCTTAC TGCCTAAACTGCTTTCAGGTGAG 
 D17S620 50 103-151 CTCTTTGTGCTTGGCAGGGT TACATTTAATGCAGGATGCC 
 D17S2196 81 139-163 CCAACATCTAGAATTAATCAGAATC ATATTTCAATATTGTAACCAGTCCC 
      
DFNB2 
(MYO7A) 
D11S4179 72 200-256 GGATGTAAGAGTAACTGG CTCCG GAAAATGTTCTGCCTGAGGG 
 D11S4186 79 154-175 ATTCTCCCAATCTATCGCTC GGGCAGTAATGATGATGTG 
 D11S4079 75 217-265 CAGCAAGATCCTGTCTCAA CTCCTTAAAGTGGGGGAGTT 
 D11S911 85 159-203 CTTCTCATGCTTGACCATTT CTTCTGAACAATTGCCACAT 
      
DFNB4 
(SLC26A4) 
D7S2420 81 240-290 CCTGTATGGAGGGCAAACTA AAATAATGACTGAGGCTCAAAACA 
 D7S496 63 129-141 AACAACAGTCAACCCACAAT GCTATAACCTCATAANAAACCAAAA 
 D7S2459 77 140-152 AAGAAGTGCATTGAGACTCC CCGCCTTAGTAAAACCC 
 D7S2456 78 238-252 CTGGAAATTGACCTGAAACCTT ACAGGGGTCTCTCACACATATTA 
      
DFNB9 
(OTOF) 
D2S365 85 164-204 ATGATTTGTGTACCTTATGTATGTT TCAATGGAGGAATCCTACTT 
 D2S2247 78 130-160 TCCATCTTTTGCGTGC CCGTGCTCTATGCCAG 
 D2S174 65 203-221 AGGCTGAATCCCACCTCC TTAGAGCACACATGGTCACTCC 
 D2S2223 63 182-200 CACTGCGCCTAGCCTC GGCGATTTATGAATAATCCTGC 
      
DFNB21 
(TECTA) 
D11S1774 60 206-226 CAAAAAGGCTTGGCGGTT GGGCATTCCCATGCTCA 
 D11S925 85 173-195 AGAACCAAGGTCGTAAGTCCTG TTAGACCATTATGGGGGCAA 
 D11S4089 75 199-213 TAATCAAAGGCTGTAGTGAATTGG ATTCCTAGTTCCCTCATAAACACTG 
 D11S4107 70 172-212 TCATTCTACAAGACTAGCATTACC GCTTGATCATGGTGTATTATCTT 
      
DFNB53 
(CO11A2l) 
D13S1236 70 108-132 GCACTTGGCCTGGGTAA AAGGGGCTGGCTCTTCA 
 D13S175 75 101-113 TATTGGATACTTGAATCTGCTG TGCATCACCTCACATAGGTTA 
      
DFNB59 
(PJVK) 
D2S2173 70 201-243 GGAGACAGAGAGTTTACATTTGAG GCCACACTTTCCTGAATC 
 D2S324 85 264-275 TTACCCACCGGGACAGT CAGCAAATGCTTCTAGGTCA 
      
      
 D11S1314 78 209-227 TTGCTACGCACTCCTCTACT GTGAAGGCAGGAAATGTGAC 
DFNB63 
(LRTOMT) 
D11S4162 75 263-269 GTTCTCCAGAGAGACAGCAC GAGAGCAACACTATTGCCC 
 D11S4140 72 189-199 TGCAACAAGGTTCCACACT CTTATGGGTGAGGGCACAG 
 D11S4184 60 263-277 CCCAGCCTTACATATTCC GCTGATGAGCAGAGGTAG 
      
DFNB24 
(RDX) 
11S1793 85 124-140 AGTCATGCATCCTCCCTGTA ATCCTGAACACATTCCTCAA 
 D11S1391 75 158-178 TGCATGCATACATACATACATACA CATCCATCCCTCTGTCTCTG 
 D11S2017 70 109-133 TTTGAATAGGAAATTAGATGGTAGG TTTGAATAGGAAATTAGATGGTAGG 
 D11S1893 58 206-258 TCCCTGGAACCTGGAT TGATGTGGGCTTTTTCAA 
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Genotyping STR markers and Linkage Anal-
ysis 
PCR of STR markers was conducted according 
to the standard procedure. The touchdown pro-
gram was used for markers amplification. Ther-
mal cycling conditions for amplifying markers 
were in accordance with previous protocols (4). 
PCR conditions were as follows: 2 μl MgCl2 (4 
mM), 2.5 μl Taq PCR buffer (10X), 0.12 μl of 
each of the primers (10 PM), 0.15 μl Taq DNA 
polymerase (5U/ul), 0.9 μl dNTP mix (10 mM) 
and 1.2 μl DNA (about 70 ng). The reaction was 
adjusted to the volume of 25 ul by ddH2O. 
Standard cycling was done in a thermocycler 
(ASTEC PC-818; ASTEC, Fukouka, Japan). STR 
markers were selected based on their physical 
distance found at NCBI UniSTS. The criteria for 
selecting these markers are as follows: greater 
heterogeneity values, and lying near or at the 
known loci. At least 4 STR markers were selected 
for linkage analysis. Table 1 summarizes the gen-
eral characteristics of the markers used in the 
study. PCR products were loaded on 12% poly-
acrylamide gel, followed by silver nitrate staining. 
Two-point and multipoint parametric LOD 
scores were calculated using Superlink (ver. 1.6) 
and GeneHunter (ver. 2.91), respectively. Hap-
lopainter version 029.5 software package was 
used for reconstruction of haplotypes (12).  
 
Results  
 
Families and clinical data 
After excluding mutations in the GJB2 gene, 60 
Iranian families segregating (ARNSHL), from 
Isfahan and Hamedan provinces (30 families 
from each province) in the center and west of 
Iran, were screened for 10 ARNSHL loci. Total-
ly, 634 individuals were studied 245 of whom 
were patients, with ages ranging from 6 months 
to 52 yr. For 45 families, PTA was consistent 
with profound HL (≥80 dB), 12 families showed 
severe HL (61-80 dB), whereas the 3 remaining 
families showed moderate HL (41-60 dB).  
 
SLINK calculation, genotyping and linkage 
analysis 
Totally, 9 families were of SLINK values ≥3.2, 
24 families had SLINK values of 2.5-3.2. The rest 
of the families presented values 1.8-2.5. Screening 
loci for homozygosity mapping in this study were 
composed of: DFNB2 (MYO7A), DFNB3 
(MYO15A), DFNB4 (SLC26A4), 
DFNB7/11(TMC1), DFNB9 (OTOF), DFNB21 
(TECTA), DFNB24 (RDX), DFNB59 (PJVK), 
DFNB63 (LRTOMT) and DFNB53 (COL11A2). 
The family members were individually genotyped 
for these markers. After genotyping of STR 
markers and linkage analysis, 14 out of the 60 
families, negative for GJB2 mutations, showed 
linkage to five different loci (Table 2). DFNB4 
was the most frequent locus in the studied 
ARNSHL series in both provinces (36.9% of the 
etiology). Three out of 30 (10%) and 2 of 30 
(6.6%) families were linked to DFNB4 in Isfahan 
and Hamedan provinces, respectively. DFNB2, 
DFNB3, and DFNB9 were ranked next after 
DFNB4. Table 3 shows the linked families and 
the maximum values for SLINK, two-point and 
multipoint LOD scores. One family (3.3%) from 
every single province was linked to DFNB9. One 
family from Hamedan Province was linked to 
DFNB7/11 (7.7% of the etiology). The haplo-
types of 3 selected linked families are shown in 
Fig. 1(a-c). 
We did not find linkage to the other loci 
(DFNB21, DFNB24, DFNB59, DFNB63 and 
FNB53) among the studied families. 
 
Discussion 
 
We determined the contribution of 10 DFNB 
loci to HL in 60 Iranian families affected with 
ARNSHL and negative for the GJB2 mutations. 
We have obtained 20% and 26% involvement of 
GJB2 mutations in ARNSHL in Hamedan and 
Isfahan provinces, respectively (unpublished da-
ta). 
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Fig. 1: Pedigree and haplotypes of the 3 Iranian families with ARNSHL, negative for GJB2 mutations, linked to 2 
known loci. a) ISF-5 is linked to DFNB4: b) IR-3 is linked to DFNB3 c) IR-14 is linked to DFNB4. Hearing im-
paired patients show homozygosity for markers. The order of markers is based on the Marshfield map 
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Table 2: Genetic etiology of ARNSHL in 60 families negative for GJB2 mutations from Isfahan and Hamedan prov-
inces 
 
Number Locus Gene Number of diagnoses % of diagnoses % of cohort 
Isfahan Hamedan Isfahan Hamedan Isfahan Hamedan 
1 DFNB2 MYO7A 1 2 7.2 15.4 3.3 6.6 
2 DFNB3 MYO15A 1 2 7.2 15.4 3.3 6.6 
3 DFNB4 SLC26A4 3 2 21.5 15.4 10 6.6 
4 DFNB7-11 TMC1 0 1 0 7.7 0 3.3 
5 DFNB9 OTOF 1 1 7.2 7.2 3.3 3.3 
Total   6 8   19.9 26.4 
 
Table 3: Maximum SLINK and LOD score (two-point and multi-point) values for the linked families 
 
Number Family ID SLINK 
value 
Linked locus Two-point LOD 
score 
Multi-point LOD 
score 
Severity HL 
 ISF-5 2.82 DFNB4 1.7 2.2 Severe-profound 
2 ISF-15 2.9 DFNB4 2.6 2.8 Moderate-profound 
3 ISF-6 3.8 DFNB4 3.1 3.2 Moderate-severe 
4 IR-14 3.28 DFNB4 2.4 2.6 Profound 
5 IR-9 1.8 DFNB4 2.2 2.3 Severe-profound 
6 IR-13 2.53 DFNB2 1.9 2.3 Severe-profound 
7 IR-30 2.8 DFNB2 2.3 2.6 Moderate-profound 
8 ISF-17 1.9 DFNB2 2 2.2 Profound 
9 IR-19 3.4 DFNB9 2.8 3.9 Severe-profound 
10 ISF-14 2.8 DFNB9 1.9 2.3 Profound 
11 IR-3 2.3 DFNB3 2.1 2.4 Profound 
12 IR-27 3.1 DFNB3 2.9 3.1 Profound 
13 ISF-23 2.4 DFNB3 2.1 2.3 Severe-profound 
14 IR-7 2.1 DFNB7-11 2 2.2 Severe-profound 
 
For the first time, we investigated the role of 10 
other loci in the etiology of HL in GJB2 negative 
families in the west and center of Iran. DFNB4 
was found to be the mostly linked locus among 
the studied families, with 3 out of 30 (10%) and 2 
of 30 (6.6%) showing linkage to it in Isfahan and 
Hamedan provinces, respectively.  
Mutations in its corresponding gene (i.e. 
SLC26A4) are the second most common cause 
of ARNSHL, after GJB2, all over the world (13). 
About 5% of ARNSHL cases in South Asia have 
been related to SLC26A4 mutations (14). Vari-
ants in this gene can cause both ARNSHL at the 
DFNB4 locus and Pendred Syndrome (PS), 
known as one of the most common forms of 
syndromic HL. PS is correlated to hypothyroid-
ism (goiter) later in life. Present data show no 
sign of PS in the studied families. Several reports 
have revealed SLC26A4 mutations in ARNSHL 
in Iranian populations. In a study, 12 families out 
of 80 (15%) Iranian families with 2 or more 
ARNSHL patients were linked to DFNB4 locus 
(15). In a recent study 12 out of 121 (9.9%) fami-
lies were linked to DFNB4 (16). Thus, our result 
shows that DFNB4 contributes mainly to 
ARNSHL in the west and center of Iran and is 
ranked second after DFNB1, which is in agree-
ment with previous studies reported from Iran 
(Table 4). The next most frequently linked locus 
in our cohort was DFNB2, which accounts for 
about 6.6% of HL etiology in Hamedan and 
3.3% in Isfahan. The related gene MYO7A, en-
coding myosin VIIA, is an action-based molecu-
lar motor converting energy from ATP hydrolysis 
into mechanical force. It also interacts with actin 
to participate in the formation of the mecha-
notransduction complex, which is critical for de-
tecting sound (17). 
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Table 4: The overview of DFNB loci frequencies obtained from in the studies on the Iranian ARNSHL patients 
 
Loci Number of 
cases 
Number of 
affected 
Frequency (%) References 
DFNB2 144 
302 
60 
4 
15 
3 
2.77 
4.96 
5 
Babanejad et al. 
Heggen et al. 
This study 
DFNB3 144 
302 
60 
8 
29 
3 
5.5 
9.6 
5 
Babanejad et al. 
Heggen et al. 
This study 
DFNB4 80 
302 
60 
12 
37 
5 
15 
12.25 
8.3 
Kahrizi et al. 
Heggen et al. 
This study 
DFNB7-11 144 
54 
60 
4 
1 
1 
2.7 
2.2 
1.66 
Babanejad et al. 
Dahaghani et al. 
This study 
DFNB9 144 
38 
60 
1 
1 
2 
0.69 
2.38 
3.3 
Babanejad et al. 
Mahdieh et al. 
This study 
 
DFNB2-linked families have been reported from 
Iran (18). 2.8% of DFNB2 involvement in 
ARNSHL etiology were reported in the studied 
Iranian cohort (19). Similarly, Sloan-Heggen et al. 
(20) using a custom targeted genomic enrichment 
method in a cohort of 302 GJB2-negative Iranian 
families, found the DFNB2 contribution to be 
5%, which is in accordance with our results (Ta-
ble 4).  
Our data show that one out of 30 families (3.3%) 
from Isfahan province and two out of 30 families 
(6.6%) from Hamedan were linked to DFNB3. 
The DFNB3 locus was first identified in the vil-
lage of Indonesia, Bengkala, with a frequency of 
9.4% among the inbred population (21). Since 
then, many mutations have been reported from 
different countries such as India, Iran, Turkey, 
and Brazil (22, 23). In Pakistan, DFNB3 is the 
third locus for ARNSHL accounting for 5% of 
ARNSHL (24). In a previous study on 40 Iranian 
ARNSHL families from Qom and Markazi prov-
inces, from center of Iran, 2 families were linked 
to DFNB3 (5.8%) (25). Therefore, the locus 
could be one common cause of ARNSHL both 
in the west and center of Iran. 
In the present study, one family (3.3%) from eve-
ry single province was linked to DFNB9 (OTOF). 
Mutations in the OTOF gene (named as homolo-
gy to Ferlin (Fer-1)) encoding otoferlin at 
DFNB9 results in ARNSHL which is sometimes 
associated with auditory neuropathy. Otoferlin is 
a member of the ferlin protein family; its role is 
in vesicle recycling and efficient and linear encod-
ing of low-intensity stimulate the synapse be-
tween inner hair cells and auditory nerve fibers 
(26). OTOF mutations have been reported from 
many countries such as Pakistan, Spain, Italy, and 
Japan with different mutation spectrum (26, 27). 
The frequency of the OTOF gene mutations has 
been reported to be 2.7% in Iran (28). It was 
screened 37 Iranian ARNSHL families from 7 
different provinces for 15 loci using linkage anal-
ysis and found 1 family (2.7%) to be linked to the 
DFNB9 locus. Similarly, in our present study, 
one family (3.3%) from each of the two provinc-
es was linked to DFNB9 (OTOF).  
Our study involves 3 families with moderate to 
severe HL highlighted by a "U" shaped audio-
gram. DFNB21 and DFNB93 are related to this 
audio profile (18, 29). Interestingly, none of the 3 
families was linked to DFNB21. Thus, the next 
step for these families involves investigating the 
DFNB93 contribution (30).  
The contribution of DFNB7/11 in Hamedan 
Province was found to be 3.3% (1/30), in line 
with the prevalence figures of 4% in Pakistan, 
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and 3.4% in Turkey. The related gene TMC1 
(Transmembrane channel-like gene I) is required 
for postnatal hair cell development. TMC1 might 
be an ion channel or transporter which mediates 
K+ homeostasis in the inner ear (31). The TMC1 
gene was initially mapped to chromosome 9q13–
q21 in two consanguineous Indian families with 
prelingual, severe-to-profound defining the 
DFNB7/11 locus (NM_138691.2). In the study 
on 144 GJB2-negative subjects, using linkage 
analysis and direct sequencing, 4 out of 144 fami-
lies (2.7%) were linked to DFNB7-11(19). More-
over, Dehaghani et al. (32), using homozygosity 
mapping on 45 ARNSHL families, detected 
1family (2.2%) to be linked to DFNB7/11. 
Therefore, the locus could be one common caus-
es of ARNSHL in the west of Iran. 
The next step of the study involves DNA se-
quencing of the corresponding genes of the 
DFNB loci in the linked families to identify the 
pathogenic mutations. Until now, 4 homozygous 
mutations have been identified in the related 
families, including 3 missense and 1 splice site 
mutations (7, 33). The identified mutations and 
their characteristics are listed in Table 5. The 
large size of some of the related genes hinders 
detection of their related mutations (34). Howev-
er, the remaining families have been considered 
for sequencing of the related genes. 
In the present study, despite the high heterogene-
ity of ARNSHL, we could detect the genetic eti-
ology in 6 out of 30 (20%) and 8 out of 30 
(26.6%) ARNSHL families, negative for GJB2 
mutations, from Isfahan and Hamedan provinc-
es, respectively. Thus, nearly 23.5% of ARNSHL 
families negative for GJB2 mutations are linked 
to 5 loci including DFNB4, DFNB2, DFNB3, 
DFNB9 and DFNB7/11. The remaining genes 
and loci could be either rare or yet to be identi-
fied (2, 28). The study is in progress by subjecting 
some of the remaining families to the next-
generation sequencing, which is a rapid and cost-
effect method.  
 
Table 5: The mutations detected in the linked families in this study 
 
Number Family ID Gene Type of 
mutation 
Nucleotide 
change 
Amino acid 
change 
1 IR-14 SLC26A4 missense c.416 G>T p.Gly139Val 
2 ISF-5 SLC26A4 Splice site c.919-2 A>G - 
3 IR-27 MYO15A missense c.6442 T>A p.Trp2148Arg 
4 IR-13 MYO7A missense c.6487 G>A p.Gly2163Ser 
 
Conclusion 
 
Using homozygosity mapping, we detected 
23.5% of the genetic etiology of GJB2- mutation 
negative ARNSHL in Isfahan and Hamedan 
provinces. This finding is interesting in view of 
the extreme genetic heterogeneity of ARNSHL 
(with over 50 genes discovered so far). Investiga-
tion of a limited number of genes could lead to 
an acceptable level of diagnostic yield. 
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